state of art in systemic management of nmcrpc
Published 5 years ago • 30 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
11:49
treatment algorithm in systemic management of advanced prostate cancer
-
14:14
management of mcrpc in china
-
10:36
state of the art - uncertainties in treatment of localised prostate cancer
-
1:18:00
urowebinar: identification and management of patients with nmcrpc
-
22:46
state of the art - has the time come to introduce early detection of prostate cancer?
-
26:28
advances in non-metastatic prostate cancer: navigating arpis and precision diagnostics
-
4:02
precision medicine in prostate cancer
-
9:30
new treatments for advanced prostate cancer
-
8:22
ep. 9: neurological aes and quality of life in treating nmcrpc
-
51:05
urowebinar: management of nmcrpc: putting current evidence into practice
-
6:10
emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy ...
-
2:38
safety outcomes of darolutamide vs apalutamide and enzalutamide in nmcrpc
-
7:50
advancements in the treatment and management of patients with castration resistant prostate cancer
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
39:02
systemic therapies for the treatment of advanced prostate cancer
-
1:33
the role of radium 223 in metastatic castration resistant prostate cancer
-
8:47
examining metastatic castration-resistant prostate cancer treatment in black patients
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
2:31
state-of-the-art cancer treatment equipment
-
5:01
fda d.i.s.c.o.: a new drug approval for non-metastatic castration-resistant prostate cancer
-
20:48
point-counterpoint: management of mcrpc
-
4:22
fatigue in men with castration resistant prostate cancer treated with enzalutamide